University of Washington Developing New COVID-19 Vaccine

(Seattle, WA) -- A new COVID vaccine is now in the late stages of testing here in Seattle. Researchers at the University of Washington used tiny protein particles to help develop GPB510 at the UW School of Medicine along with SK Bioscience. They say it has more protective antibodies than the current Oxford/AstraZeneca vaccine, and is expected to work at relatively low doses.

While the vaccine awaits FDA approval here stateside, another country is already lined up to buy; South Korea could sign off within a month. A company there is leading clinical trials and the country has already agreed to buy ten-million doses.